Impetigo

Explore clinical trials studying Impetigo. Study availability and eligibility vary by location and protocol.

27 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Impetigo trial results

Completed

Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo

NCT01670032

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
Locations: SRCR, Inc Bell Gardens, California, United States

Skin Care research Inc Boca Raton, Florida, United States

Eastern Research, Inc Hialeah, Florida, United States

Cyn3rgy Research Gresham, Oregon, United States

View all 13 locations

View Trial Details

Completed

A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo

NCT01803035

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +10 more
Locations: Dr. Robert Reid Cabral Children Hospital Santo Domingo, Dominican Republic

Institute of Dermatology and and Skin Surgery Dr. Hubert Bogaert Diaz Santo Domingo, Dominican Republic

View Trial Details

Completed

Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients

NCT01171326

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +10 more
Locations: Lev Yasmin Clinic Netanya, Israel

View Trial Details

Completed

EU PV for Retapamulin-Prescribing

NCT01153828

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
Locations: Not specified

View Trial Details

Completed

Safety and Efficacy of Topical NVC-422 Gel in Impetigo

NCT01367314

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
Locations: Hospital Infantil Dr. Robert Reid Cabral Santo Domingo, Dominican Republic

Instituto Dermatológico Santo Domingo, Dominican Republic

View Trial Details

Completed

A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection

NCT01223222

Conditions: Atopic Dermatitis, Bacterial Infections, Bacterial Infections and Mycoses, +27 more
Locations: Debreceni Egyetem Orvos-és Egészségtudományi Debrecen, Hungary

Miskolci Semmelweis Ignác Egészegügyi Központ és Miskolc, Hungary

Pécsi Tudományegyetem általános Orvostudom´nyi Centum Pécs, Hungary

Szeged Univesrity Hospital Szeged, Hungary

View Trial Details

Completed

Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory

NCT00884728

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Ectoparasitic Infestations, +15 more
Locations: Menzies School of Health Research Casuarina, Northern Territory, Australia

View Trial Details

Impetigo

Impetigo trial results

Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo

A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo

Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients

EU PV for Retapamulin-Prescribing

Safety and Efficacy of Topical NVC-422 Gel in Impetigo

A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection

Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory

Related conditions